News

Tell us about your exciting accomplishments!

OVPR staff is excited about the breakthroughs in research and scholarly accomplishments on our campus. If you have been awarded a grant, submitted a paper for publication or been notified that your research is being published in a scholarly journal, please contact us at hscora@ouhsc.edu so we can share the news with the rest of the OUHSC research community.

"The ORA submission process: A review for new investigators"
New PI Training 04-20-16 Final

Other helpful information

On this page, you will also find useful Institutional Data that you may be asked to provide when submitting a proposal.   Please let us know if there is additional information or links you would like to see on our site. Simply complete our Suggestion Form.

ORA Research News - Monday, September 16, 2019

Don’t Forget to Link Your ORCID iD to Your eRA Commons Profile

Graduate students to senior scientists are encouraged to register for an ORCID account (https://orcid.org/register) and

link it to their eRA Commons personal profile

(https://era.nih.gov/erahelp/ppf/default.htm#PPF_Help/8_2_orcid.htm%3FTocPath%3D_____13). Starting October 1, 2019,

ORCID identifiers will be required for individuals supported by institutional research training, career development, and

other research education awards. xTrain appointments will not be accepted for agency review if potential appointees do

not have an ORCID iD linked to their eRA personal profile. ORCID iDs will also be required for PD/PIs on individual

fellowship and career development applications submitted for due dates on or after January 25, 2020.

 

 

“Privacy and Health Research in a Data-Driven World” Live Webcast – Thursday, September 19, 2019 from

8:15AM to 4:15PM EDT.

Sessions will include:

•            Is Privacy a Casualty of Advancing Research?

•            Approaches to Protecting Privacy and Confidentiality

•            Protecting Privacy and Confidentiality: A Shared Responsibility

For additional information go to:  https://www.hhs.gov/ohrp/education-and-outreach/exploratory-workshop/2019-workshop/index.html

 

 

The Office of Technology Development will offer the Innovation to Impact Series Session 2  “Aligning Your

Research With Industry.” Learn how to gather useful insights from the market; Common customer discovery mistakes; and

Funding to support market discovery. Meredith Wilkerson, Licensing Officer -Life Sciences and Andrew Pollock, Interim Exec.

Director of OTD will be presenting.

This session will occur on September 25th  from Noon- 1:00 pm in Biomedical Research Center Building,  Room 103. Lunch

will be provided.  Please RSVP to rashaffer@ou.edu by September 23rd. Space is limited to the first 15 attendees.

 

 

National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), Small Business

Innovation Research (SBIR) and Small Business Technology Transfer (STTR) experts are coming to Oklahoma

City to conduct an SBIR Outreach Event.

Wednesday, September 25th from 9:00 am to 4:00 pm at the OUHSC PHF Conference Center. 

See the attached document for additional information.

 https://research.ouhsc.edu/Portals/1329/Assets/Documents/NIH Contract SBIR Topics.docx?ver=2019-08-18-153311-077

 

Office of Technology Development presents a third opportunity to engage with industry

(for more information go to http://www.ou.edu/otd/ICO, or email otd@ou.edu for specific submission details):

Almirall is looking to sponsor academic research for target identification, validation, and/or to advance pre-clinical therapeutic

opportunities into clinical settings for “novel targets, pathways, or therapeutic candidates relating to chronic immune-inflammatory

disease” (expiration 9/30/19).  Funding up to $250K per project to be awarded by Almirall in November 2019.

 

 

Harold Hamm Diabetes Center (HHDC) Research Symposium CALL FOR ABSTRACTS 

The abstract submission deadline for the HHDC 2019 Research Symposium is Friday, October 4th. Abstracts must be received

by 5 p.m. HHDC 2019 Research Symposium will be held on Friday, November 15, 2019 at the Samis Education Center in Children’s

Hospital in Oklahoma City. The Symposium will consist of selected oral presentations, a poster session, and Symposia talks by

P. Darrell Neufer, PhD, Professor, East Carolina University, Matthew Rodeheffer PhD, Associate Professor, Yale University and

Scott Summers, PhD, Professor and Chair, The University of Utah.  For abstract submission guidelines and to RSVP for this free

event, please go to: https://hammdiabetescenter.org/Research/Symposium  Please contact Katie-Hoefling@ouhsc.edu with any

questions for this event.

 

 

Save the Date – ORA Noon Conference

Navigating the ORA Proposal Submission Process

Speaker(s):       Caitlin Novotny, Sponsored Programs Administrator, Office of Research Administration

Offered:             September 25, 2019  LIB-299 12-1pm

Overview:          This session will cover the basics of proposal preparation and map out the process of submission through the

Office of Research Administration. We will discuss what your Sponsored Programs Administrator looks for during the pre-award

review, such as budget considerations, eligibility, and compliance with applicable rules and policies. We will also cover topics

related to proposal submission, such as grant routing forms and the systems used to submit federal grants. The overall goal of

this presentation is to provide a basic understanding of and advice on proposal preparation and submission

 

 

NIH NOTICES

 

Notice of Special Interest to Encourage Eligible NIH BRAIN Initiative Awardees to Apply for PA-18-906 Research Supplements

to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) (NOT-MH-19-038)
https://grants.nih.gov/grants/guide/notice-files/NOT-MH-19-038.html

 

Notice of Pre-Application Webinar for RFA-AT-20-001, Preclinical Screening for Natural Product Drug Interactions (R21) and

RFA-AT-20-002, Center of Excellence for Natural Product Drug interaction Research (U54) (NOT-AT-19-034)
https://grants.nih.gov/grants/guide/notice-files/NOT-AT-19-034.html

 

Pre-Application Webinar for RFA-CA-19-033 " Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors

(U01 Clinical Trial Required)" (NOT-CA-19-068)
https://grants.nih.gov/grants/guide/notice-files/NOT-CA-19-068.html

 

The National Institutes of Health (NIH) Sexual & Gender Minority Research Office (SGMRO) Announces Mid-Atlantic Regional

Workshop on Sexual and Gender Minority (SGM)-Related Health Research (NOT-OD-19-142)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-142.html

 

Request for Information (RFI): Soliciting Additional Input to the All of Us Research Program 2019 Tribal Consultation (NOT-PM-19-004)
https://grants.nih.gov/grants/guide/notice-files/NOT-PM-19-004.html

 

Notice of Increased Budget Limits and NINDS Participation in PAS-19-316 "Advancing Research on Alzheimer's Disease (AD)

and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)" (NOT-AG-19-040)
https://grants.nih.gov/grants/guide/notice-files/NOT-AG-19-040.html

 

Notice of Change to Information relevant to Specific Institutes/Centers in PAR-19-274, "Dissemination and Implementation

Research in Health (R01 Clinical Trial Optional)" (NOT-AR-19-040)
https://grants.nih.gov/grants/guide/notice-files/NOT-AR-19-040.html

 

Notice of Change to Information relevant to Specific Institutes/Centers in PAR-19-275, "Dissemination and Implementation

Research in Health (R21 Clinical Trial Optional)" (NOT-AR-19-041)
https://grants.nih.gov/grants/guide/notice-files/NOT-AR-19-041.html

 

Notice of Correction to Award Budget for RFA HD-20-006 "US Children with Perinatal HIV who were Born Internationally

(R01 Clinical Trial Optional)" (NOT-HD-19-025)
https://grants.nih.gov/grants/guide/notice-files/NOT-HD-19-025.html

 

NHLBI Announces Participation in PA-18-932 "Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations

(R01 Clinical Trial Optional)" (NOT-HL-19-719)
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-19-719.html

 

Notice to Extend, PA-18-400 "Research on Autism Spectrum Disorders (R21-Clinical Trial Optional)"
(NOT-MH-19-045)

https://grants.nih.gov/grants/guide/notice-files/NOT-MH-19-045.html

 

Notice to Extend, PA-18-401 "Research on Autism Spectrum Disorders (R01-Clinical Trial Optional)"
(NOT-MH-19-046)

https://grants.nih.gov/grants/guide/notice-files/NOT-MH-19-046.html

 

Notice to Extend, PA-18-399 "Research on Autism Spectrum Disorders (R03-Clinical Trial Optional)"
(NOT-MH-19-047)

https://grants.nih.gov/grants/guide/notice-files/NOT-MH-19-047.html

 

Notice to Extend, PAR-18-479, "Detecting and Preventing Suicide Behavior, Ideation and Self-Harm in Youth in Contact with the

Juvenile Justice System (R01 Clinical Trial Required)" (NOT-MH-19-049)
https://grants.nih.gov/grants/guide/notice-files/NOT-MH-19-049.html

 

Notice to Extend, PAR-18-228, "Pilot Studies to Detect and Prevent Suicide Behavior, Ideation and Self-Harm in Youth in Contact

with the Juvenile Justice System (R34 Clinical Trial Required)" (NOT-MH-19-050)
https://grants.nih.gov/grants/guide/notice-files/NOT-MH-19-050.html

 

Notice of Intent to Publish a Funding Opportunity Announcement for the Pediatric HIV AIDS Cohort Study Program Project Grant

Applications (P01 Clinical Trial Not Allowed) (NOT-HD-19-024)
https://grants.nih.gov/grants/guide/notice-files/NOT-MH-19-050.html

 

Notice of Special Interest: High-Priority Research Topics for PA-19-053 and PA-19-056 (NOT-AG-19-037)
https://grants.nih.gov/grants/guide/notice-files/NOT-AG-19-037.html

 

Notice of Special Interest (NOSI) of NIDCD and NEI in Supporting Research on Usher Syndrome
(NOT-DC-19-007)

https://grants.nih.gov/grants/guide/notice-files/NOT-DC-19-007.html

 

Notice of Special Interest: Administrative Supplements to Support Emerging Physician-Scientists to Develop Research

Expertise in Diabetes, Endocrinology and Metabolic Diseases (NOT-DK-19-015)
https://grants.nih.gov/grants/guide/notice-files/NOT-DK-19-015.html

 

Notice of Special Interest: Research to Improve Pre-Pregnancy Care and Enhance Healthy Birth Intervals
(NOT-HD-19-019)

https://grants.nih.gov/grants/guide/notice-files/NOT-HD-19-019.html

 

Notice of Special Interest: Mechanisms Underlying the Contribution of Sleep Disturbances to Pain
(NOT-HD-19-020)

https://grants.nih.gov/grants/guide/notice-files/NOT-HD-19-020.html  

  

Please Note:  When only one application is allowed per Institution according to the sponsor

instructions, a one-page letter of intent summarizing the proposed project should be submitted

to the Vice President for Research at least one month prior to the application deadline (unless

otherwise noted).  The letters of intent will be reviewed and a single application will be chosen  

for submission from the University.

 

NIH DEADLINES

 

Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R01 Clinical Trial Not Allowed)

(PAR-19-357) – Deadline January 8, 2020 and January 8, 2021

https://grants.nih.gov/grants/guide/pa-files/PAR-19-357.html

 

Planning Grant for Global Infectious Disease Research Training Program (D71 No Clinical Trials Allowed)
(PAR-19-362) – Deadline November 12, 2019 and October 28, 2020

https://grants.nih.gov/grants/guide/pa-files/PAR-19-362.html

 

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
(PAR-19-363) – Deadline October 5, 2019

https://grants.nih.gov/grants/guide/pa-files/PAR-19-363.html

 

Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R21 Clinical Trial Not Allowed)

(PAR-19-364) – Deadline January 8, 2020 and January 8, 2021
https://grants.nih.gov/grants/guide/pa-files/PAR-19-364.html

 

Revision Applications for Mechanisms of Drug Resistance (R01 Clinical Trials Not Allowed) (RFA-CA-19-049)
Deadline October 24, 2019 and June 24, 2020

https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-049.html

 

Revision Applications for Mechanisms of Drug Resistance (U01 Clinical Trials Not Allowed)
(RFA-CA-19-050) – Deadline October 24, 2019 and June 24, 2020

https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-050.html

 

Revision Applications for Mechanisms of Drug Resistance (U54 Clinical Trials Not Allowed)
(RFA-CA-19-051) – Deadline October 24, 2019 and June 24, 2020 

https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-051.html

 

Revision Applications for Mechanisms of Drug Resistance (P01 Clinical Trials Not Allowed)
(RFA-CA-19-052) – Deadline  October 24, 2019 and June 24, 2020

https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-052.ht

 

Revision Applications for Mechanisms of Drug Resistance (P50 Clinical Trials Not Allowed)
(RFA-CA-19-053) - Deadline October 24, 2019 and June 24, 2020

https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-053.html

 

The National Drug Abuse Treatment Clinical Trials Network (UG1 Clinical Trial Required)
(RFA-DA-20-024) – Deadline November 15, 2019 

https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-20-024.html

 

Prevention of Lower Urinary Tract Symptoms (PLUS) Research Consortium Clinical Research Centers

(U01 Clinical Trial Optional) (RFA-DK-19-015) – Deadline November 7, 2019
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-19-015.html 

 

Prevention of Lower Urinary Tract Symptoms (PLUS) Research Consortium Scientific and Data Coordinating Center

(U24 Clinical Trial Optional) (RFA-DK-19-016) – Deadline November 7, 2019

https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-19-015.html

 

Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research

(R21 Clinical Trial Not Allowed) (RFA-HD-20-020) – Deadline November 1, 2019

https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-20-020.html

 

Trans-Agency Blood-Brain Interface Program (R61/R33 - Clinical Trials Not Allowed) (RFA-HL-20-021)
Deadline December 2, 2019 and October 19, 2020

https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-20-021.html

 

Mechanistic Basis of TDP-43-dependent Pathobiology in Common Dementias (R01 Clinical Trial not Allowed)

(RFA-NS-20-005) – Deadline November 15, 2019  

https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-20-005.html

 

Peripheral Pathology in the Lewy Body Dementias (R01 Clinical Trial Not Allowed)
(RFA-NS-20-014) - Deadline December 3, 2019

https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-20-014.html

Print